Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6012ce2ccf64fbc34ba201c9f11ada92 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1018 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 |
filingDate |
2017-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33b87536b283bb5ed76396dde7203a98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8de9b0c39164d99e4f492e75f6e481cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19aafee872576984554cfd897e5884fb |
publicationDate |
2019-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3423484-A1 |
titleOfInvention |
Human neutralizing antibodies binding to influenza b neuraminidase |
abstract |
The present invention provides influenza neuraminidase (NA)-binding human antibodies, which are capable of specifically binding to and neutralizing at least one influenza B virus strain from the B/Victoria lineage and/or at least one influenza B virus strain from the B/Yamagata lineage, as well as antigen-binding fragment thereof. The invention furthermore relates to the use of said antibodies or antigen- binding fragments in the diagnosis, prophylaxis and/or treatment of influenza infection. |
priorityDate |
2016-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |